Menu
Not yet recruiting NCT06606834

Assessment of the Uterus Using Ultrasonographic Elastography in Women with Dysmenorrhea

Observational Primary Dysmenorrhea

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: sonoelastography.
Who it may be relevant to
Registry conditions: Primary Dysmenorrhea. Basic parameters: 18 years — 40 years · Female.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Turkey (Türkiye)
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

The aim of this study is to perform sonoelastographic assessment of the uterus in patients diagnosed with primary dysmenorrhea and to compare these measurements with sonoelastographic evaluations of the uteri in asymptomatic individuals. This will enable, for the first time, the demonstration of whether the elasticity of the myometrial tissue contributes to the etiology of primary dysmenorrhea. Secondary Objectives: To determine whether there is a correlation between the severity of primary dysmenorrhea and ultrasonographic markers.

Interventions

  • Diagnostic test sonoelastography
    Elasticity is defined as the ability of an organ or tissue to return to its original shape after being deformed by an applied force or stress. Based on this principle, sonoelastography is a technique used to assess the elasticity of tissues and organs during ultrasonography. This assessment allows measurement of changes in stiffness of soft tissues following physiological or pathological processes.

Primary outcome measures

  • SWE Tecnique [Time frame: 1 year]

Eligibility criteria

Inclusion criteria

  • Women aged 18-40 years.
  • Women with primary dysmenorrhea who are willing to participate in the study.
  • Women without primary or secondary dysmenorrhea who agree to participate as a control group.

Exclusion criteria

  • Women with secondary dysmenorrhea.
  • Patients with underlying uterine or adnexal pathologies (e.g., endometrial polyps, adenomyosis, uterine fibroids, adnexal masses, ovarian pathologies and cysts) identified via ultrasonography.
  • Individuals with a history of uterine surgery.
  • Individuals with a history of pelvic surgery.
  • Individuals who have delivered via normal spontaneous vaginal delivery or cesarean section.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Observational model
Other

Study locations

Turkey (Türkiye) · 1 center
  • Ufuk University — Ankara

Identifiers

NCT: NCT06606834 · 24.06.11.02/01

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗